ArticleDermatology and therapy2025

Complete/Near-Complete Itch Response Observed in Patients with Moderate-to-Severe Atopic Dermatitis Initiating Dupilumab: 3-Year, Real-World, Interim Data from the PROSE Registry.

Neal Bhatia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.